Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review)
International Journal of Oncology · 09.11.2026 · 69 (6) · 1-27
DOI: 10.3892/ijo.2026.5955 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 09.11.2026. Verfasst von Ying Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Drug Resistance, Neoplasm, Epigenesis, Genetic, Lysine.
Abstract (Originalsprache)
Lysine lactylation couples glycolytic flux with epigenetic regulation, driving cancer stemness and therapeutic resistance. The Warburg effect generates L‑lactate, which through enzymatic (AARS1/2, HBO1, KAT8) and non‑enzymatic mechanisms deposits lactyl groups on histones and non‑histone proteins. This modification sustains cancer stem cell self‑renewal via histone mark deposition at stemness gene promoters and non‑histone modification of key regulators (SOX9 and β‑catenin). Concurrently, lactylation enhances DNA repair, suppresses ferroptosis and stabilizes stemness‑associated transcription factors, conferring resistance to chemotherapy, targeted agents and immunotherapy. Crosstalk with acetylation, ubiquitination and phosphorylation adds regulatory complexity. Preclinical targeting of lactate metabolism, lactyltransferases, or delactylases shows therapeutic promise, while lactylation‑based signatures may stratify patient responses. The present review synthesized current evidence establishing lactylation as a metabolic‑epigenetic node and summarized convergent resistance mechanisms that may inform future therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China.
- Department of Pathology, The First Hospital of Nanchang City, Nanchang, Jiangxi 330000, P.R. China.
Zitieren
APA
Yang, Y., Zhang, N., Wang, D., Ye, D., Zhang, Y., & Li, X. (2026). Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review). International Journal of Oncology, 69(6), 1-27. https://doi.org/10.3892/ijo.2026.5955
Vancouver
Yang Y, Zhang N, Wang D, Ye D, Zhang Y, Li X. Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review). International Journal of Oncology. 2026;69(6):1-27. doi:10.3892/ijo.2026.5955
BibTeX
@article{Yang2026,
author = {Yang, Ying and Zhang, Nan and Wang, Dan and Ye, Dongmei and Zhang, Yun and Li, Xiaoju},
title = {Metabolic‑epigenetic coupling via lysine lactylation drives cancer stemness and multidrug resistance (Review)},
journal = {International Journal of Oncology},
year = {2026},
volume = {69},
number = {6},
pages = {1--27},
doi = {10.3892/ijo.2026.5955}
}
EUVIMED